Home › Liver Cancer › Tennessee › Nashville
Liver Cancer clinical trials in Nashville, TN
5 studies for Liver Cancer are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
DESTINY-PANTUMOUR04
RecruitingObservational study
- Research Site, Nashville
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
RecruitingPhase 1
- SCRI Oncology Partners /ID# 272750, Nashville
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
RecruitingPhase 1
- Sarah Cannon Research Center, Nashville
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
- Sarah Cannon Research Institute, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Nashville
About Liver Cancer
The most common form of liver cancer in adults is hepatocellular carcinoma. Learn about diagnosis, treatment and taking part in research studies.
More about Liver Cancer on MedlinePlus
Liver Cancer trials in other cities
- Houston, TX14 studies
- Los Angeles, CA11 studies
- Cleveland, OH11 studies
- Dallas, TX10 studies
- Boston, MA9 studies
- Chicago, IL8 studies
- St. Louis, MO8 studies
- Durham, NC7 studies
- Philadelphia, PA7 studies
- San Francisco, CA6 studies
- New York City, NY6 studies
- Washington, DC6 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.